期刊文献+

CEA单克隆抗体C_(50)的^(99m)Tc标记试剂盒的初步应用

Preliminary application of ^(99m)Tc-labeled anti-CEA monoclonal antibody kit
下载PDF
导出
摘要 目的进行癌胚抗原CEA单克隆抗体C50的99mTc标记试剂盒的初步应用。方法进行99mTc-C50试剂盒的安全限度检测,进行99mTc-C50试剂盒的动物实验应用研究,进行3例结直肠癌患者的RII。结果 (1)注射试剂后3只家兔的体温升高值均在规定范围内,5只受试小鼠注射试剂后48 h内无一死亡;(2)荷瘤裸鼠RII,药物注入后6 h肿瘤部位有放射性聚集,24 hT/NT比值为3.46~4.68,24 h后,经活体组织测量发现瘤体与血液的T/NT比值为1.84,与肌肉的比值高达16.1;(3)3例大肠癌患者中复发、转移灶均显示出阳性结果,T/NT比值在4.68~12.36之间。结论本标记化合物无热源性,无毒性,符合国家药典的规定,为99mTc-C50能较好地应用于临床研究提供依据。 Objective To assess the application of 99mTc-labeled anti-CEA monoclonal antibody(99mTc-C50) kit.Methods The safety of 99mTc-C50 kit was tested in rabbits.Radioimmunoimaging(RII) with 99mTc-C50was performed in nude mice bearing human colorectal cancer and 3 patients with recurrent colorectal carcinoma.Results The temperature rose within the safe limit after 99mTc-C50injection in 3 rabbits.Five mice all survived 48h after 99mTc-C50 injection.In cancer-bearing nude mice,the radioactivity increased in tumor site 6 hours after 99mTc-C50 injection,the T/NT ratio reached 3.46 ~ 4.68 24 hours after.The measurement in biopsy specimens showed that T/NT ratio in blood was 1.84,and that in muscle was 16.1.In 3 patients with relapsed colorectal cancer,the metastatic tumors showed positive results with T/NT ratio of 4.68~12.36.Conclusion The preliminary application indicates that 99mTc-C50 kit might be applied in clinical detection of metastatic colorectal cancer with safety.
出处 《同济大学学报(医学版)》 CAS 2013年第3期32-35,共4页 Journal of Tongji University(Medical Science)
关键词 癌胚抗原 单抗 试剂盒 CEA monoclonal antibody kit TC
  • 相关文献

参考文献9

  • 1王荣福.核素示踪技术分子功能影像在肿瘤诊治中应用及进展[J].肿瘤学杂志,2008,14(8):615-619. 被引量:6
  • 2段东,朱玉泉,李少林.^(99m)Tc-EGFR-McAb用于荷人肺腺癌裸鼠的放射免疫显像研究[J].重庆医科大学学报,2010,35(5):695-699. 被引量:2
  • 3吕中伟,蔡海东,娄继权,邱桂林,黄飚,顾伟中.^(99m)Tc标记结肠癌单克隆抗体片段CEA-Fab的研制方法[J].同济大学学报(医学版),2004,25(4):343-344. 被引量:1
  • 4Allison L,wingenberger Z, Michael S, et al. In-vivobiodistribution and safety of "mTc-LLP2A-HYNIC incanine non-hodgkin lymphoma [ J]. Plos One,2012,7(4): e34404.
  • 5David M,Goldenberg,Chien-Hsing Chang, et al.Pretargeted Molecular Imaging and Radioimmunoth-erapy [J]. Theranostics,2012,2(5) : 523 -540.
  • 6Guus AMS. van Dongen, Alex J,et al. PET imagingwith radiolabeled antibodies and tyrosine kinaseinhibitors : immuno-PET and TKI-PET [ J ]. TumourBiol,2012,33(3) : 607-615.
  • 7Victoria VL, William MG. Epige-netics and colorectalcancer [ J ]. Nat Rev Gastroenterol Hepatol,2011, 8(12): 686-700.
  • 8John M, Pagel, Dana C, et al. Pretargeted radioim-munotherapy using Anti-CD45 monoclonal antibodiesto deliver radiation to murine hematoly-mphoid tissuesand human myeloid leukemia[ J]. Cancer Res,2009,69(1) : 185-192.
  • 9Brom M, Joosten L, Oyen WJ, et al. Improvedlabelling of DTPA-and DOTA-conjugated peptides andantibodies with 111 In in HEPES and MES buffer[ J].EJ Nmmi Res,2012,27(2) : 4.

二级参考文献45

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部